Patents by Inventor Min-Seok Kang

Min-Seok Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210241531
    Abstract: A method and apparatus provide a virtual clothing wearing service based on deep-learning. A virtual clothing wearing server based on deep-learning includes a communicator configured to receive a user image and a v clothing image; a memory configured to store a program including first and second deep-learning models; a processor configured to generate an image of virtually dressing a virtual wearing clothing on a user. The program is configured to: generate, by the first deep-learning model, a transformed virtual wearing clothing image by transforming the virtual wearing clothing image in accordance with a body of the user in the user image based on the user image and the virtual wearing clothing image, and generate, by the second deep-learning model, the virtual wearing person image by dressing the transformed virtual wearing clothing on the body of the user based on the user image and the transformed virtual wearing clothing image.
    Type: Application
    Filed: November 26, 2020
    Publication date: August 5, 2021
    Inventors: Hyug Jae Lee, Rok Kyu Lee, Min Seok Kang, Myoung Hoon Cho
  • Patent number: 10995758
    Abstract: A pump for circulating water includes an upper housing 10 formed with an inlet 11 and an outlet 12 of fluid; a lower housing 20 arranged in a lower side of the upper housing 10, having a space formed therein; an inner housing 30 having an edge part interposed between the upper housing 10 and the lower housing 20, and an impeller receiving space 31 formed in a middle part; an impeller 50 received inside the upper housing 10 and in the impeller receiving space 31 to be rotatably installed; a rotor 60 installed inside an outer circumference of the impeller 50; a spring 65 installed between a lower surface of the impeller and the inner housing; and a stator 70 installed inside the lower housing 20.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: May 4, 2021
    Assignee: NEW MOTECH CO., LTD.
    Inventors: Jeong Cheol Jang, Kyoung Joo Lee, Hyun Sung Yang, Min Seok Kang
  • Publication number: 20210024358
    Abstract: A particle with a yolk-shell structure including a shell including carbon; and a care including silicon (Si) provided inside the shell, wherein at least a part of the shell is spaced apart from the core, and the particle with the yolk-shell structure has a micropore volume of 0.15 cm3/g or less, and a method for preparing the same.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 28, 2021
    Applicants: LG Chem, Ltd., INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
    Inventors: Jonghyun CHAE, Won Cheol YOO, Min Seo KIM, Jangbae KIM, Min Seok KANG
  • Publication number: 20200290934
    Abstract: Provided are an additive composition for a tile cement mortar and a tile cement mortar including the additive composition for a tile cement mortar. The provided additive composition for a tile cement mortar includes cellulose ether and urea, wherein the amount of the urea is from 5 parts by weight to 43 parts by weight based on 100 parts by weight of the cellulose ether.
    Type: Application
    Filed: March 23, 2018
    Publication date: September 17, 2020
    Applicant: LOTTE FINE CHEMICAL CO., LTD.
    Inventors: Yun Na Kim, Nak Woon Choi, Bong Jin Kwon, Min Seok Kang, Hyun Ji Jeong
  • Patent number: 10376480
    Abstract: A biguanide derivative compound with N1-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK? and inhibition of cancer cell proliferation in a low dose, compared to conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: August 13, 2019
    Assignee: ImmunoMet Therapeutics Inc.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Chang Hee Min, Young Woong Kim, Min Seok Kang, Byung Kyu Oh, Se Hwan Park, Yong Eun Kim, Duck Kim, Ji Sun Lee, Ju Hoon Oh
  • Publication number: 20190219056
    Abstract: A pump for circulating water includes an upper housing 10 formed with an inlet 11 and an outlet 12 of fluid; a lower housing 20 arranged in a lower side of the upper housing 10, having a space formed therein; an inner housing 30 having an edge part interposed between the upper housing 10 and the lower housing 20, and an impeller receiving space 31 formed in a middle part; an impeller 50 received inside the upper housing 10 and in the impeller receiving space 31 to be rotatably installed; a rotor 60 installed inside an outer circumference of the impeller 50; a spring 65 installed between a lower surface of the impeller and the inner housing; and a stator 70 installed inside the lower housing 20.
    Type: Application
    Filed: September 18, 2017
    Publication date: July 18, 2019
    Applicant: NEW MOTECH CO., LTD.
    Inventors: Jeong Cheol JANG, Kyoung Joo LEE, Hyun Sung YANG, Min Seok KANG
  • Patent number: 10252943
    Abstract: Provided are a cement mortar additive for extrusion molding, a cement mortar for extrusion molding, and an extrusion-molded product. The disclosed cement mortar additive for extrusion molding includes hydrogelated cellulose ether.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: April 9, 2019
    Assignee: LOTTE FINE CHEMICAL CO., LTD.
    Inventors: Bon Hyeok Gu, Tae Hong Kim, Won Hee Lee, Min Seok Kang, Myung Jae Lee, Myeong Ho Jeon, Gyu Chul Lee
  • Publication number: 20180256520
    Abstract: A biguanide derivative compound with N1-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK? and inhibition of cancer cell proliferation in a low dose, compared to conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.
    Type: Application
    Filed: May 10, 2018
    Publication date: September 13, 2018
    Inventors: Sung Wuk KIM, Sung Soo JUN, Chang Hee MIN, Young Woong KIM, Min Seok KANG, Byung Kyu OH, Se Hwan PARK, Yong Eun KIM, Duck KIM, Ji Sun LEE, Ju Hoon OH
  • Patent number: 10061244
    Abstract: A fixing apparatus for an image forming apparatus includes: a fixing belt; a pressure roller configured to face the fixing belt; a nip forming member configured to be disposed inside the fixing belt and press the fixing belt to the pressure roller to form a nip; and first and second guide bushings configured to be disposed at both ends of the nip forming member, respectively, in which the first and second guide bushings each support both end supports both ends of the fixing belt in a state in which a part thereof is movable.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: August 28, 2018
    Assignee: S-PRINTING SOLUTION CO., LTD.
    Inventor: Min-seok Kang
  • Patent number: 9993446
    Abstract: A biguanide derivative compound with N1-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK? and inhibition of cancer cell proliferation in a low dose, compared to conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: June 12, 2018
    Assignee: Immunomet Therapeutics Inc.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Chang Hee Min, Young Woong Kim, Min Seok Kang, Byung Kyu Oh, Se Hwan Park, Yong Eun Kim, Duck Kim, Ji Sun Lee, Ju Hoon Oh
  • Publication number: 20180143572
    Abstract: A fixing apparatus for an image forming apparatus includes: a fixing belt; a pressure roller configured to face the fixing belt; a nip forming member configured to be disposed inside the fixing belt and press the fixing belt to the pressure roller to form a nip; and first and second guide bushings configured to be disposed at both ends of the nip forming member, respectively, in which the first and second guide bushings each support both end supports both ends of the fixing belt in a state in which a part thereof is movable.
    Type: Application
    Filed: August 9, 2017
    Publication date: May 24, 2018
    Applicant: S-Printing Solution Co., Ltd.
    Inventor: Min-seok KANG
  • Patent number: 9862978
    Abstract: The present invention relates to a method for easily preparing (2RS)-amino-(3S)-hydroxy-butyric acid, which is a chiral amino acid, in a high yield and a high purity using a chemical synthesis and enzymatic reduction reaction; an intermediate therefor; and a method for preparing the intermediate.
    Type: Grant
    Filed: February 24, 2014
    Date of Patent: January 9, 2018
    Assignee: Aminologics Co. Ltd.
    Inventors: Min Seok Kang, Hyun II Lee, Ki Nam Uhm, Jin Hyang Kim
  • Publication number: 20170210669
    Abstract: Provided are a cement mortar additive for extrusion molding, a cement mortar for extrusion molding, and an extrusion-molded product. The disclosed cement mortar additive for extrusion molding includes hydrogelated cellulose ether.
    Type: Application
    Filed: May 8, 2015
    Publication date: July 27, 2017
    Inventors: Bon Hyeok GU, Tae Hong KIM, Won Hee LEE, Min Seok KANG, Myung Jae LEE, Myeong Ho JEON, Gyu Chul LEE
  • Patent number: 9579947
    Abstract: A coupled torsion beam axle for vehicles may include a torsion beam disposed in a vehicle width direction and trailing arms disposed at both ends of the torsion beam in a length direction of a vehicle body, wherein the torsion beam has an opened cross section formed in a reverse ā€œUā€ shape by press-forming one sheet member machined so that lengths of right and left sides are different from each other on the basis of a center, and cross section widths which are different from each other along vehicle width directions of both sides on the basis of the center between the trailing arms of both sides, and front and rear surfaces formed in a wave shape along the vehicle width directions of both sides on the basis of the center.
    Type: Grant
    Filed: November 21, 2015
    Date of Patent: February 28, 2017
    Assignees: Hyundai Motor Company, Kia Motors Corporation, Dong Hee Industrial Co., Ltd., Hwashin Co. Ltd.
    Inventors: Sang Rak Kim, Jung Taek Lim, Soo Chul Lee, Hak Il Kim, Min Seok Kang, Eui Keun Jeong
  • Publication number: 20160325596
    Abstract: A coupled torsion beam axle for vehicles may include a torsion beam disposed in a vehicle width direction and trailing arms disposed at both ends of the torsion beam in a length direction of a vehicle body, wherein the torsion beam has an opened cross section formed in a reverse ā€œUā€ shape by press-forming one sheet member machined so that lengths of right and left sides are different from each other on the basis of a center, and cross section widths which are different from each other along vehicle width directions of both sides on the basis of the center between the trailing arms of both sides, and front and rear surfaces formed in a wave shape along the vehicle width directions of both sides on the basis of the center.
    Type: Application
    Filed: November 21, 2015
    Publication date: November 10, 2016
    Applicants: Hyundai Motor Company, Kia Motors Corporation, Dong Hee Industrial Co., Ltd., Hwashin Co. Ltd.
    Inventors: Sang Rak KIM, Jung Taek LIM, Soo Chul LEE, Hak II KIM, Min Seok KANG, Eui Keun JEONG
  • Publication number: 20160317478
    Abstract: A biguanide derivative compound with N1-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK? and inhibition of cancer cell proliferation in a low dose, compared to conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.
    Type: Application
    Filed: July 11, 2016
    Publication date: November 3, 2016
    Inventors: Sung Wuk Kim, Sung Soo Jun, Chang Hee Min, Young Woong Kim, Min Seok Kang, Byung Kyu Oh, Se Hwan Park, Yong Eun Kim, Duck Kim, Ji Sun Lee, Ju Hoon Oh
  • Patent number: 9416098
    Abstract: A biguanide derivative compound with N1-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK? and inhibition of cancer cell proliferation in a low dose, compared to conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.
    Type: Grant
    Filed: January 6, 2011
    Date of Patent: August 16, 2016
    Assignee: IMMUNOMET THERAPEUTICS INC.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Chang Hee Min, Young Woong Kim, Min Seok Kang, Byung Kyu Oh, Se Hwan Park, Yong Eun Kim, Duck Kim, Ji Sun Lee, Ju Hoon Oh
  • Publication number: 20160017389
    Abstract: The present invention relates to a method for easily preparing (2RS)-amino-(3S)-hydroxy-butyric acid, which is a chiral amino acid, in a high yield and a high purity using a chemical synthesis and enzymatic reduction reaction; an intermediate therefor; and a method for preparing the intermediate.
    Type: Application
    Filed: February 24, 2014
    Publication date: January 21, 2016
    Applicant: AMINOLOGICS Co., Ltd.
    Inventors: Min Seok KANG, Hyun Il LEE, Ki Nam UHM, Jin Hyang KIM
  • Publication number: 20130053061
    Abstract: A localization system includes terminals and a server. The terminal includes an antenna unit to receive a wireless signals, a distance determining unit to determine a distance relative to other terminals using intensity information of the wireless signals, a direction detection unit to obtain an orientation of the terminal, and a control unit to control the terminal. The server includes a calculating unit to calculate a distance between the terminals based on intensity information, and a memory unit to store the distance information. The control unit may calculate a relative location of other terminals using a triangulation method based on the distance information between the terminals. The control unit may determine a location and orientation of another terminal based on a forward direction or orientation of the terminal obtained by the direction detecting unit of the terminal and the relative location of other terminals.
    Type: Application
    Filed: August 22, 2012
    Publication date: February 28, 2013
    Applicant: PANTECH CO., LTD.
    Inventors: Min Seok KANG, Hyeong Jae CHOI
  • Publication number: 20120283299
    Abstract: A biguanide derivative compound with N1-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK? and inhibition of cancer cell proliferation in a low dose, compared to conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.
    Type: Application
    Filed: January 6, 2011
    Publication date: November 8, 2012
    Applicant: HANALL BIOPHARMA CO., LTD.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Chang Hee Min, Young Woong Kim, Min Seok Kang, Byung Kyu Oh, Se Hwan Park, Yong Eun Kim, Duck Kim, Ji Sun Lee, Ju Hoon Oh